Business Brief -- Imcera Group Inc.:
   Board Approves Expansion
   Of Capacity for a Product
Mallinckrodt will expand production capabilities of the
St. Louis plant where Optiray currently is manufactured; that
project is expected to be complete in slightly more than a
year.
   Additionally, the company said, it is in "advanced stages
of discussion" with Irish authorities on plans to build an
Optiray facility in that country. Sales of Optiray began in
Europe last year.
   Imcera has interests in medical products, specialty
chemicals, and animal feed and pharmaceuticals.